Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deciphera Pharmaceuticals (DCPH)
NASDAQ:DCPH
RESEARCH TOOLSreports
Deciphera Pharmaceuticals (DCPH) Ownership - Who Owns Deciphera Pharmaceuticals?
227 Followers
Deciphera Pharmaceuticals (DCPH) Ownership Overview
31.66% Insiders
11.52% Mutual Funds
12.09% Other Institutional Investors
44.74% Public Companies and
Individual Investors
The ownership structure of Deciphera Pharmaceuticals (DCPH) stock is a mix of institutional, retail and individual investors. Approximately 23.60% of the company’s stock is owned by Institutional Investors, 31.66% is owned by Insiders and 44.74% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 24, 2024 | Brightstar Associates Llc >10% Owner | Bought | $481 |
| Feb 20, 2024 | Matthew Sherman Evp & Chief Medical Officer | Sold | $40820 |
| Feb 20, 2024 | Sold | $46986 | |
| Feb 20, 2024 | Jama Pitman Svp, Chief Development Officer | Sold | $35388 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $170494 | |
| Dec 31, 2023 | Bought | $1006060 | |
| Dec 31, 2023 | Bought | $6391335 | |
| Dec 31, 2023 | Sold | $9306606 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,788,024 | Institution | 7.04% | 84,910,312 | |
| 3,010,595 | Institution | 3.66% | 44,165,429 | |
| 2,663,758 | Institution | 3.24% | 39,077,330 | |
| 2,627,909 | Institution | 3.20% | 38,551,425 | |
| 1,850,695 | Institution | 2.25% | 27,149,696 | |
| 878,425 | Institution | 1.07% | 12,886,495 | |
| 792,714 | Institution | 0.96% | 11,629,114 | |
| 692,140 | Institution | 0.84% | 10,153,694 | |
| 609,682 | Institution | 0.74% | 8,944,035 | |
| 582,191 | Institution | 0.71% | 8,540,742 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,627,909 | Institution | 3.20% | 38,551,425 | |
| 878,425 | Institution | 1.07% | 12,886,495 | |
| 792,714 | Institution | 0.96% | 11,629,114 | |
| 692,140 | Institution | 0.84% | 10,153,694 | |
| 609,682 | Institution | 0.74% | 8,944,035 | |
| 582,191 | Institution | 0.71% | 8,540,742 | |
| 434,143 | Institution | 0.53% | 6,368,878 | |
| 366,577 | Institution | 0.45% | 5,377,685 | |
| 359,232 | Institution | 0.44% | 5,269,933 | |
| 292,366 | Institution | 0.36% | 4,289,009 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,763,512 | Institution | 2.15% | 27,740,044 | |
| 1,786,687 | Institution | 2.17% | 26,210,698 | |
| 1,257,277 | Institution | 1.53% | 18,444,254 | |
| 880,693 | Institution | 1.07% | 13,853,301 | |
| 367,450 | Institution | 0.45% | 5,390,492 | |
| 323,453 | Institution | 0.39% | 4,745,056 | |
| 274,012 | Institution | 0.33% | 4,019,756 | |
| 199,000 | Institution | 0.24% | 3,130,270 | |
| 172,336 | Institution | 0.21% | 2,528,169 | |
| 161,806 | Institution | 0.20% | 2,373,694 |
FAQ
Who Owns Deciphera Pharmaceuticals (DCPH)?
According to the latest TipRanks data, approximately 12.09% of the company's stock is held by institutional investors, 31.66% is held by insiders, and 44.74% is held by retail investors.
What percentage of Deciphera Pharmaceuticals (DCPH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.09% of Deciphera Pharmaceuticals (DCPH) stock is held by institutional investors.
What percentage of Deciphera Pharmaceuticals (DCPH) stock is held by retail investors?
According to the latest TipRanks data, approximately 44.74% of Deciphera Pharmaceuticals (DCPH) stock is held by retail investors.
Who owns the most shares of Deciphera Pharmaceuticals (DCPH)?
James E. Flynn owns the most shares of Deciphera Pharmaceuticals (DCPH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.